Methylprednisolone for status migrainous vertigo and cephalic status migrainosus.
Robbins
Matthew S
MS
Wang
Dong
D
DeOrchis
Vincent S
VS
D004334:Drug Administration Schedule; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D008775:Methylprednisolone / Q000008:administration & dosage*; D008875:Middle Aged; D008881:Migraine Disorders / Q000150:complications* / Q000209:etiology* / Q000503:physiopathology; D016896:Treatment Outcome; D014717:Vertigo / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D015837:Vestibular Diseases / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D014725:Vestibular Nerve / Q000187:drug effects / Q000503:physiopathology; D014722:Vestibule, Labyrinth / Q000187:drug effects / Q000503:physiopathology
D005938:Glucocorticoids; D008775:Methylprednisolone